Ebola virus disease
ICD-10 A98.4 · ICD-11 1D60.0

Treatment of Ebola Virus Disease in Children and Neonates with Hypoglycaemia

Hypoglycaemia — defined as blood glucose below 54 mg/dL (< 3 mmol/L) — requires prompt management in children and neonates with Ebola virus disease. The choice of glucose preparation in this population is specifically guided by EVD supportive care principles.

Clinical Scenario

This protocol addresses children and neonates with EVD who present with hypoglycaemia (glucose < 54 mg/dL or < 3 mmol/L). Paediatric patients are at particular risk, and the selection of the glucose preparation used for correction is explicitly defined within EVD management guidelines for this age group.

Approach

Management centres on intravenous dextrose correction using D10 (10% glucose) — not D50. The full protocol specifies the method of administration, the maintenance infusion strategy, and the glucose monitoring schedule after correction.

Clinical Target

Normalisation of blood glucose, confirmed by re-check at 15 minutes after correction.

Instant Access to Structured Evidence-Based Regimens

References

For paediatric patients, use D10 to treat hypoglycaemia. Do not use D50, which can lead to rebound hypoglycaemia.

Hypoglycaemia is defined as < 3 mmol/l or < 54 mg/dl in adults and children in the context of EVD.

Neonates and children: slow IV push bolus of 2–5 ml/kg of 10% glucose.

Re-check glucose 15 minutes after correcting.

View source ↗